Showing results (1171-1180 of 1,281) with videos related to

Sort By:
Pageof 129
Gut|July 20, 2007
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potentialL Valfrè di Bonzo, I Ferrero, C Cravanzola, et al.
Scientific Reports|June 15, 2017
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate CellsErica Novo, Gianmarco Villano, Cristian Turato, et al.
Theranostics|August 15, 2019
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatmentsMaeva Dufies, Oleksandr Grytsai, Cyril Ronco, et al.
Cell Reports. Medicine|September 21, 2022
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinomaAnais Hagege, Esma Saada-Bouzid, Damien Ambrosetti, et al.
The American Journal of Pathology|March 1, 1997
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patientsS Uccini, M C Sirianni, L Vincenzi, et al.
Travel Medicine and Infectious Disease|November 28, 2020
Acquisition of multidrug-resistant bacteria and colistin resistance genes in French medical students on internships abroadThi Loi Dao, Van Thuan Hoang, Amal Magmoun, et al.
European Review for Medical and Pharmacological Sciences|April 20, 2022
Features of fragile people with SARS-CoV-2 infection in isolation in a COVID-19 hotel in Rome, ItalyC Stingone, A Latini, L Gianserra, et al.
European Review for Medical and Pharmacological Sciences|June 1, 2022
Author Correction: Features of fragile people with SARS-CoV-2 infection in isolation in a COVID-19 hotel in Rome, ItalyC Stingone, A Latini, L Gianserra, et al.
Theranostics|March 15, 2019
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5Sandy Giuliano, Maeva Dufies, Papa Diogop Ndiaye, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 16, 2021
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell ProliferationBeatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Pageof 129